Candel Therapeutics, Inc. (CADL)

Last Closing Price: 5.32 (2026-11-18)

Common Equity (Quarterly)

Common Equity: The sum of all common equity items.

Candel Therapeutics, Inc. (CADL) had Common Equity of $131.59M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-21.87M
--
--
$22.98M
$-22.98M
$1.11M
$-21.87M
$-21.87M
$-21.87M
$-21.87M
$-21.87M
$-21.87M
$-22.98M
$-22.81M
77.39M
77.39M
$-0.28
$-0.28
Balance Sheet Financials
$207.35M
$1.90M
$3.76M
$211.11M
$27.39M
$48.20M
$52.13M
$79.52M
Common Equity
$131.59M
$131.59M
$131.59M
78.45M
Cash Flow Statement Financials
$-58.34M
$-0.89M
$142.61M
$120.15M
$203.53M
$83.39M
$6.96M
--
--
Fundamental Metrics & Ratios
7.57
--
--
0.27
0.37
--
--
--
--
--
--
$-59.22M
--
--
--
--
--
--
--
-16.62%
-16.62%
-10.36%
-12.17%
$1.68
$-0.77
$-0.75